Vomiting News and Research

RSS
Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.
Prior chemotherapy extends postpalliative survival in pancreatic cancer

Prior chemotherapy extends postpalliative survival in pancreatic cancer

Targeting noradrenergic system combats gait freezing in Parkinson’s patients

Targeting noradrenergic system combats gait freezing in Parkinson’s patients

Updated survival data from Takeda’s brentuximab vedotin Phase II trial on HL

Updated survival data from Takeda’s brentuximab vedotin Phase II trial on HL

Investigational drug slows metastatic breast cancer progression

Investigational drug slows metastatic breast cancer progression

Amylin, Alkermes announce results from BYDUREON clinical study on type 2 diabetes

Amylin, Alkermes announce results from BYDUREON clinical study on type 2 diabetes

Positive results from Amgen Sensipar/Mimpara Phase 3 trial for HPT, CKD

Positive results from Amgen Sensipar/Mimpara Phase 3 trial for HPT, CKD

No benefits to polychemotherapy after surgery in gastric cancer

No benefits to polychemotherapy after surgery in gastric cancer

New nanomedicine cancer treatments promise to reduce severity of side effects

New nanomedicine cancer treatments promise to reduce severity of side effects

Savient announces results from KRYSTEXXA Phase III trials on gout-related kidney disease

Savient announces results from KRYSTEXXA Phase III trials on gout-related kidney disease

Debiopharm announces results from Debio 0932 Phase I study on cancer

Debiopharm announces results from Debio 0932 Phase I study on cancer

Iron and micronutrient-enriched foodstuffs can fight against anaemia

Iron and micronutrient-enriched foodstuffs can fight against anaemia

Bayer announces updated data from radium-223 dichloride Phase III trial on CRPC

Bayer announces updated data from radium-223 dichloride Phase III trial on CRPC

Positive updated interim data from Exelixis’ cabozantinib phase 2 trial on CRPC

Positive updated interim data from Exelixis’ cabozantinib phase 2 trial on CRPC

Lilly announces final results from ALIMTA Phase III study on NSCLC

Lilly announces final results from ALIMTA Phase III study on NSCLC

Results from Celgene’s ABRAXANE plus gemcitabine clinical study on resectable pancreatic cancer

Results from Celgene’s ABRAXANE plus gemcitabine clinical study on resectable pancreatic cancer

Exelixis reports positive interim data from cabozantinib phase 2 trial on HCC

Exelixis reports positive interim data from cabozantinib phase 2 trial on HCC

New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors

New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

Data from several clinical trials of ADCETRIS to be presented at ASCO annual meeting

Data from several clinical trials of ADCETRIS to be presented at ASCO annual meeting

Genentech’s T-DM1 Phase III study on HER2-positive mBC meets primary endpoint

Genentech’s T-DM1 Phase III study on HER2-positive mBC meets primary endpoint

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.